Tonabersat (SB-220453) a novel benzopyran with anticonvulsant properties attenuates trigeminal nerve-induced neurovascular reflexes

被引:38
作者
Parsons, AA
Bingham, S
Raval, P
Read, S
Thompson, M
Upton, N
机构
[1] SmithKline Beecham Pharmaceut, Neurosci Res, Harlow CM19 5AW, Essex, England
[2] SmithKline Beecham Pharmaceut, Med Chem, Harlow CM19 5AW, Essex, England
关键词
tonabersat; carabersat; lamotrigine; trigeminal nerve; neurovascular reflex; migraine; cluster headache;
D O I
10.1038/sj.bjp.0703932
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effects of tonabersat (SB-220453) were evaluated on trigeminal nerve ganglion stimulation-induced sensory-autonomic neurovascular reflexes in the anaesthetized cat. Comparisons were made to intravenous administration of carabersat (SB-204269), and to valproate, gabapentin and lamotrigine following intraduodenal administration. 2 There were no effects on resting blood pressure, heart rate, carotid blood flow or carotid vascular resistance for any compound evaluated. 3 Trigeminal nerve ganglion stimulation increased carotid blood flow by 65% and reduced vascular resistance by 41% with minimal effect on blood pressure (<10%) and no effect on heart rate. Intravenous infusion of tonabersat or carabersat (both 3.4 <mu>mol h(-1)) produced time related reductions in stimulation-induced responses with a maximal inhibition (relative to control) of 30 +/- 7% (n = 4), at 240 min for tonabersat and 33 +/- 4% (n = 3) at 180 min for carabersat. Tonabersat (11.5 mu mol h(-1)) produced a similar inhibitory effect (32 +/- 9%, n = 4) after 120 min of infusion. 4 Following intraduodenal administration of tonabersat, the maximal inhibition of nerve stimulation-induced responses was 55 +/- 4% at 120 min (n = 4) for tonabersat 10 mg kg(-1), and 24 +/- 2% after 180 min for 1 mg kg(-1) (n = 4). 5 Intraduodenal administration of sodium valproate (10 or 100 mg kg(-1) n = 4/group) had no effect on neurovascular reflexes. Maximal inhibition of nerve ganglion-stimulated reductions in carotid vascular resistance were observed at 150 min for lamotrigine (50 mg kg(-1), 52 +/- 12%, n = 4) and lgabapentin (100 mg kg(-1), 17 +/- 13%, n = 3). Lamotrigine 10 mg kg(-1) produced 22 +/- 11% (n = 3) inhibition after 180 min. 6 These data demonstrate blockade of trigeminal parasympathetic reflexes with tonabersat, carabersat and other anticonvulsants. These agents may therefore have therapeutic benefit in conditions where this type of reflex is evident.
引用
收藏
页码:1549 / 1557
页数:9
相关论文
共 45 条
[1]   THE INFLUENCE OF THE TRIGEMINAL GANGLION ON CAROTID BLOOD-FLOW IN ANESTHETIZED GUINEA-PIGS [J].
BEATTIE, DT ;
CONNOR, HE .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (01) :262-266
[2]   THE ANTIMIGRAINE DRUG, SUMATRIPTAN (GR43175), SELECTIVELY BLOCKS NEUROGENIC PLASMA EXTRAVASATION FROM BLOOD-VESSELS IN DURA MATER [J].
BUZZI, MG ;
MOSKOWITZ, MA .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 99 (01) :202-206
[3]   Identification of a series of 1,2,3,4-tetrahydroisoquinolinyl-benzamides with potential anticonvulsant activity [J].
Chan, WN ;
Hadley, MS ;
Harling, JD ;
Herdon, HJ ;
Jerman, JC ;
Orlek, BS ;
Stean, TO ;
Thompson, M ;
Upton, N ;
Ward, RW .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1998, 8 (20) :2903-2906
[4]   Synthesis of novel trans-4-(substituted-benzamido)-3,4-dihydro-2H-benzo[b]-pyran-3-ol derivatives as potential anticonvulsant agents with a distinctive binding profile [J].
Chan, WN ;
Evans, JM ;
Hadley, MS ;
Herdon, HJ ;
Jerman, JC ;
Morgan, HKA ;
Stean, TO ;
Thompson, M ;
Upton, N ;
Vong, AK .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (23) :4537-4539
[5]   Identification of (-)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent [J].
Chan, WN ;
Evans, JM ;
Hadley, MS ;
Herdon, HJ ;
Jerman, JC ;
Parsons, AA ;
Read, SJ ;
Stean, TO ;
Thompson, M ;
Upton, N .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (02) :285-290
[6]   The actions of valproate and neurosteroids in a model of trigeminal pain [J].
Cutrer, FM ;
Moskowitz, MA .
HEADACHE, 1996, 36 (10) :579-585
[7]   Possible mechanisms of valproate in migraine prophylaxis [J].
Cutrer, FM ;
Limmroth, V ;
Moskowitz, MA .
CEPHALALGIA, 1997, 17 (02) :93-100
[8]   The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord [J].
Dickenson, AH ;
Chapman, V ;
Green, GM .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1997, 28 (05) :633-638
[9]   Neuropeptides in headache [J].
Edvinsson, L ;
Goadsby, PJ .
EUROPEAN JOURNAL OF NEUROLOGY, 1998, 5 (04) :329-341
[10]   NEUROPEPTIDES IN THE CEREBRAL-CIRCULATION - RELEVANCE TO HEADACHE [J].
EDVINSSON, L ;
GOADSBY, PJ .
CEPHALALGIA, 1995, 15 (04) :272-276